Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-05

Clinical Trial Update: A Study of Sertraline to Prevent PTSD [Phase 4]

View source ↗

Summary

Phase 4 study evaluating sertraline for prevention of posttraumatic stress disorder after trauma has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Sertraline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Posttraumatic Stress Disorder, Depression | Phase 4 | Status: COMPLETED | Results posted: 2014-08-05